Hanping Feng

Fzata, Inc.

NIH Rank #2471
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$3.1M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,471
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.1M across 3 grants · National rank #2471.

Top grants by award amount

Hanping Feng's NIH grant portfolio, ranked by award amount.

  • 1UG3NS135350-01A1UG3
    A novel oral immunotherapy for chronic visceral pain of irritable bowel syndrome
    $2.1M
    award amount
  • 5R01AI148357-05R01
    Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies
    $621.3K
    award amount
  • 5R01AI148270-05R01
    Characterization of neutralizing antitoxins and epitopes in Clostridium difficile patients
    $386.3K
    award amount

Affiliations

Institutions that have administered grants for Hanping Feng.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Fzata, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2471
  6. 2024
    Entered Top 25% Nationally
    Ranked #2471
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Hanping Feng.